SastaSundar in talks to raise $100 million, a digital e-pharmacy startup, is in talks with existing Japanese investors Mitsubishi Corp and Rohto Pharmaceuticals, besides other global private equity players to raise around $100 million (₹740 crore) as part of a series-D funding.

It expects to line up around $25 million in calendar year 2021 itself in a bid to build a war chest for expanding its health services across India amid the raging Covid pandemic, a top company executive said.

Liking this story?

Get one mail covering top tech news of the day in under 5 minutes!

Please wait…

The company, whose mobile app has seen over two million downloads, will shortly register with the National Health Authority (NHA), even as it prepares to run customised Covid-19 vaccination camps at big corporate offices and large housing complexes with partner hospital chains across the country. “We are talking to our Japanese investors, Mitsubishi Corp and Rohto Pharma and several other leading global PE firms to raise another $100 million in multiple tranches as part of a fourth round of funding,” SastaSundar‘s founder and executive chairman BL Mittal told ET. The company is targeting raising the funds over two years.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.